Britain’s Indivior wins preliminary injuction against generic rival

July 13 (Reuters) – A U.S. court has granted Indivior a preliminary injunction blocking India’s Dr. Reddy’s Laboratories from selling cut-price versions of the British drugmaker’s best-selling opioid addiction treatment in the United States.

The ruling comes days after Indivior scrapped its full-year guidance citing an “accelerated” loss in U.S. market share to the cheaper version of star drug Suboxone launched by the Indian firm. ( Reporting by Justin George Varghese in Bengaluru; Editing by Patrick Graham and Diane Craft)

Learn More about best forex signal

What do you think?

0 points
Upvote Downvote

Total votes: 0

Upvotes: 0

Upvotes percentage: 0.000000%

Downvotes: 0

Downvotes percentage: 0.000000%

U.S. Air Force says completed final tests for Boeing KC-46 program

Brazilian retail billionaire Rocha drops out of presidential race